Hackensack Meridian Jersey Shore University Medical Center Provides Patient New Jersey’s First GammaTile® Brain Tumor Treatment

Hackensack Meridian Neuroscience Institute at Jersey Shore University Medical Center successfully performed the first GammaTile® implant in the state. The device was implanted in a patient with recurrent meningioma, a brain tumor, to deliver radiation immediately at the time of surgery, targeting residual cancer cells to help prevent recurrence while minimizing harm to healthy tissue.

Gamma Knife Radiosurgery to Treat a Brain Meningioma

Shari Benedict fell down a flight of eight stairs after losing her balance. A bystander called for an ambulance, which took Shari to The Valley Hospital Emergency Department in Ridgewood, NJ where she was diagnosed with a brain meningioma, the size of a golf ball, a condition Shari was unaware of. Shari underwent a craniotomy and Gamma Knife radiosurgery to treat her condition. She is now beginning the next chapter in her life.

Bridging the gap between AI and the clinic Rapprocher l’IA de la pratique clinique

Researchers trained machine learning algorithms on data from more than 62,000 patients with a meningioma. Their goal was to find statistical associations between malignancy, survival, and a series of basic clinical variables including tumour size, tumour location, and surgical procedure.

Des chercheurs ont entraîné des algorithmes d’apprentissage automatique à partir des données de plus de 62 000 patients ayant un méningiome. L’objectif était de déceler des associations statistiques entre la malignité, le temps de survie et d’autres variables cliniques de base telles que la taille de la tumeur, son emplacement et la nature de l’intervention chirurgicale effectuée.